Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Nephros, Inc.

Nephros, Inc. (NEPH) Stock Overview

Explore Nephros, Inc.’s financial performance, market position, analyst ratings, and future outlook.

NEPH●NASDAQ
HealthcareMedical - Instruments & Supplies
$3.71
$0.18(4.63%)
U.S. Market opens in 5h 31m

Nephros, Inc. (NEPH)

Meyka AI Score

Z

Key Financials

Market Cap40.3M
P/E Ratio23.71
EPS (TTM)$0.06
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$5.47
3 Months$3.96
1 Year Target$5.19

NEPH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Nephros, Inc. (NASDAQ: NEPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Nephros, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NEPH on the NASDAQ shows an RSI of 37.43, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.19 for the NASDAQ listing.

Key metrics behind Nephros, Inc.'s NASDAQ-traded stock include a P/E ratio of 23.71 and a market capitalization of 40.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NEPH on the NASDAQ.

Price Performance (NASDAQ: NEPH)

1-Day Change
-4.63%
5-Day Change
-9.95%
1-Month Change
-18.46%
3-Month Change
3.92%
6-Month Change
31.10%
Year-to-Date (YTD) Change
-23.98%
1-Year Change
-21.56%
3-Year Change
154.11%
5-Year Change
-57.70%
All-Time (Max) Change
-99.65%

Contact Information

https://www.nephros.com
201 343 5202
380 Lackawanna Place, South Orange, NJ, 07079

Company Facts

360 Employees
IPO DateSep 21, 2004
CountryUS
Actively Trading

Frequently Asked Questions